Protein Nitrogen Balance and Adequacy

This activity will cover a wide array of issues regarding protein nitrogen balance and adequacy. The relationship between protein intake and urea nitrogen appearance will be discussed, as well as the clinical and nutritional implications of urea kinetics and dialysis adequacy.  

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Interpret the relationship between protein intake and urea nitrogen appearance
  • Discuss the evidence related to the potential toxicity of urea
  • Assess the clinical and nutritional implications of urea kinetics and dialysis adequacy
PLEASE NOTE: YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE ENROLLING IN THIS EDUCATIONAL ACTIVITY. 

Once you're logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target Audience

  • Dietitians
Accreditation/Designation of Credit Statements:

Dietitian

The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours.       

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.50 Attendance
  • 1.50 CDR CPEUs
Course opens: 
02/15/2017
Course expires: 
02/15/2019
Cost:
$35.00
Rating: 
5
Faculty Disclosures:

Andre Kaplan, MD, FACP, FASN 
Professor of Medicine
University of Connecticut Health Center
Farmington, CT
Disclosure: Research Grants: Vital Therapies,Inc., Nipro Corporation; Other: Vital Therapies, Inc., Nipro Corporation

Planning Committee Disclosures:

Kristine D’Angelo David, RD
Medical Science Liaison
Sigma-Tau Pharmaceuticals, Inc.
Gaithersburg, MD
Disclosure: Receives a salary from Sigma-Tau Pharmaceuticals.

Beth Shanaman, RD
Registered Dietitian
Northwest Kidney Centers
Seattle, WA
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden 
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Danielle Nathan
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Anna Okoniewski
CME/CE Activities Manager
National Kidney Foundation    
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Meredith Marinaro, MS, RD, CSR
Registered Dietitian
UConn Dialysis
Farmington, CT
Disclosure: Received a consulting fee from Keryx Biopharmaceuticals for her role on the speakers bureau and advisory board in the area of renal osteodystrophy.
 

Available Credit

  • 1.50 Attendance
  • 1.50 CDR CPEUs

Accreditation Period

Course opens: 
02/15/2017
Course expires: 
02/15/2019

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals